We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a ...

Stoke City legend Mike Pejic runs the rule over Narcis Pelach's progress or otherwise during his first two months in charge at the bet365 Stadium ...

Incoming Democratic Senator-elect Ruben Gallego of Arizona says building authentic connections with working-class voters can ...

Fintel reports that on November 15, 2024, Redburn Atlantic upgraded their outlook for Autolus Therapeutics plc - Depositary Receipt () (NasdaqGS:AUTL) from Neutral to Buy. Analyst Price Forecast ...

Analyst Sean Lee CFA from H.C. Wainwright maintained a Buy rating on Plus Therapeutics (PSTV – Research Report) and keeping the price ...

Tributes have poured in for a 'remarkable' former Stoke-on-Trent Lord Mayor who dedicated years to championing the ...

Microsoft explains why Windows 11's new Outlook is better than Mail & Calendar but the reasons aren't convincing enough.

Piper Sandler analyst Biren Amin lowered the firm’s price target on Allogene Therapeutics (ALLO) to $9 from $11 and keeps an Overweight ...

Nektar continues to make progress with rezpegaldesleukin, with results from phase 2 atopic dermatitis study expected in H1'25 ...

PTC Therapeutics' gene therapy is already approved in the European ... while European stocks rose on hopes of a better growth ...